Published in Blood on May 17, 2010
Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed) (2012) 1.28
TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood (2011) 1.10
Biology of tissue factor pathway inhibitor. Blood (2014) 1.01
Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A (2013) 1.01
Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood (2015) 0.93
Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant (2011) 0.93
Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo. Blood (2013) 0.87
Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS One (2014) 0.85
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2013) 0.84
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). J Biol Chem (2013) 0.81
New insights into the biology of tissue factor pathway inhibitor. J Thromb Haemost (2015) 0.79
Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein. J Biol Chem (2010) 0.78
Alternatively spliced tissue factor pathway inhibitor: functional implications. Front Biosci (Schol Ed) (2011) 0.78
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood (2014) 0.78
Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci (Elite Ed) (2012) 0.77
Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor. Curr Opin Hematol (2013) 0.77
Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder. J Clin Invest (2013) 0.77
Platelet tissue factor pathway inhibitor modulates intravascular coagulation. Thromb Res (2012) 0.75
Platelets: Context-Dependent Vascular Protectors or Mediators of Disease. Arterioscler Thromb Vasc Biol (2015) 0.75
Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use. PLoS One (2017) 0.75
An acquired, calcium-dependent, factor X inhibitor. Blood Cells Mol Dis (2013) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The coagulation cascade: initiation, maintenance, and regulation. Biochemistry (1991) 6.29
The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol (1988) 5.84
Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem (1991) 4.82
Blood coagulation. Annu Rev Biochem (1980) 4.27
Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood (1990) 3.38
Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem (1988) 2.09
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature (1989) 2.07
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (2006) 2.01
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood (2008) 1.90
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A (1990) 1.67
Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry (1986) 1.62
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem (1998) 1.46
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood (1992) 1.46
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood (1996) 1.39
Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res (1989) 1.37
Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation (2003) 1.32
Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A (1994) 1.25
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem (1993) 1.23
Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis (1994) 1.16
Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor. J Thromb Haemost (2008) 1.08
The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (1994) 1.08
Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrinolysis (1993) 1.08
Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem (1996) 1.03
Regulation of coagulation by protein S. Curr Opin Hematol (2008) 1.03
Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity. Biochemistry (2001) 1.03
Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding. Circulation (2004) 1.00
Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. J Thromb Haemost (2009) 0.99
Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb Haemost (1994) 0.97
Plasma contains protein S monomers and multimers with similar direct anticoagulant activity. J Thromb Haemost (2006) 0.96
Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding. J Biol Chem (2000) 0.94
Protein S multimers and monomers each have direct anticoagulant activity. J Thromb Haemost (2006) 0.91
Self-association of human protein S. Biochemistry (2000) 0.91
Concentrations of binding protein and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Methods Enzymol (1981) 0.90
The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa. J Biol Chem (2008) 0.87
Analyses of protein S function. Blood (2005) 0.81
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci U S A (2006) 2.07
Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood (2007) 1.71
Cleavage of the ADAMTS13 propeptide is not required for protease activity. J Biol Chem (2003) 1.39
Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation (2003) 1.32
Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation (2002) 1.15
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J Clin Invest (2002) 1.13
Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II. Blood (2011) 1.12
Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa. J Biol Chem (2008) 1.11
Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem (2004) 1.10
TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood (2011) 1.10
Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency. Blood (2008) 1.06
Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost (2005) 1.06
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP). Thromb Haemost (2006) 1.00
Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding. Circulation (2004) 1.00
Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases. J Biol Chem (2012) 0.97
Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor. J Biol Chem (2011) 0.92
Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z. Blood (2012) 0.85
Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX. J Biol Chem (2007) 0.84
Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis. Am J Pathol (2006) 0.81
Contribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction. Crit Care Med (2013) 0.80
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice. Front Biosci (2002) 0.77
Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia. Thromb Haemost (2015) 0.75